ArticleJournal of clinical microbiology2020
Impact of Changes in Clinical Microbiology Laboratory Location and Ownership on the Practice of Infectious Diseases.
Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 14 citations in OpenAlex.
- Integrated morpho-biochemical, molecular, phylogenetic, and thermodynamic characterization of Bacillus isolates from ecologically distinct Indian soils.Molecular biology reports · 2026Article
- Advanced molecular detection, bioinformatics, and artificial intelligence era in medical laboratory science education.Journal of microbiology & biology education · 2026Article
- Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey.Infectious diseases and therapy · 2026Article
- An Interactive, Case-Based Microbiology Laboratory Session for First-Year Medical Students.Cureus · 2026Article
- Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection.JAC-antimicrobial resistance · 2026Article
- Changes in Access to Comprehensive Clinical Microbiology Laboratory Testing in Tennessee From 2019-2024.Open forum infectious diseases · 2026Article
- Pediococcus pentosaceus strain SPARC2 as a potential probiotic food supplement: genomic insight, probiotic potential, and biosafety profiling in BALB/c mice.Archives of microbiology · 2025Article
- Performance evaluation of early growth isolates for automated and manual broth microdilution antimicrobial-susceptibility testing.Journal of clinical microbiology · 2025Article
- Whether to continue combining carbapenems to treat carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia in critically ill patients: a retrospective efficacy and safety analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Challenges and opportunities for incentivising antibiotic research and development in Europe.The Lancet regional health. Europe · 2023Review
- Diagnostic delays in infectious diseases.Diagnosis (Berlin, Germany) · 2022Article
- Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey.Annals of intensive care · 2021Article
- Impact of delays to incubation and storage temperature on blood culture results: a multi-centre study.BMC infectious diseases · 2021Article
- Practical Aspects and Considerations When Planning a New Clinical Microbiology Laboratory.Clinics in laboratory medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of onsite clinical microbiology laboratories in hospitals is decreasing, likely related to the business model for laboratory consolidation and labor shortages, and this impacts a variety of clinical practices, including that of banking isolates for clinical or epidemiologic purposes. To determine the impact of these trends, infectious disease (ID) physicians were surveyed regarding their perceptions of offsite services. Clinical microbiology practices for retention of clinical isolates for future use were also determined. Surveys were sent to members of the Infectious Diseases Society of America's (IDSA) Emerging Infections Network (EIN). The EIN is a sentinel network of ID physicians who care for adult and/or pediatric patients in North America and who are members of IDSA. The response rate was 763 (45%) of 1,680 potential respondents. Five hundred forty (81%) respondents reported interacting with the clinical microbiology laboratory. Eighty-six percent of respondents thought an onsite laboratory very important for timely diagnostic reporting and ongoing communication with the clinical microbiologist. Thirty-five percent practiced in institutions where the core microbiology laboratory has been moved offsite, and an additional 7% (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.